Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Disease × fluorocholine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Neoplasms 5 Carcinoma, Hepatocellular 4 Parathyroid Neoplasms 1 Multiple Endocrine Neoplasia Type 1 1 Liver Diseases 1 Hyperparathyroidism, Primary 1 Disease 1 Breast Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 6 Dexamethasone 6 Blood Specimen Collection 6 Cyclophosphamide 5 Prednisone 4 Positron Emission Tomography Computed Tomography 4 Mammography 4 Lenalidomide 4 Colonoscopy 4 Tomography, X-Ray Computed 3 Surveys and Questionnaires 3 Melphalan 3 Biopsy 3 weifuchun 2 pembrolizumab 2 fluciclovine F-18 2 daratumumab 2 carfilzomib 2 Preoperative Exercise 2 Positron-Emission Tomography 2 Methods 2 Magnetic Resonance Imaging 2 Injections 2 Gemcitabine 2 Cytarabine 2 Control Groups 2 Biopsy, Fine-Needle 2 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 2 vistusertib 1 venetoclax 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04965454 2025-05-01

ExTRACT-HCC

Queen's Medical Center

Phase 2 Recruiting

Gastrointestinal

Disease, Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡